(Q46789177)

25 December 2017

title

Cytomegalovirus viremia in Thai HIV-infected patients on antiretroviral therapy: prevalence and associated mortality (English)

1 reference

25 December 2017

0 references

5

1 reference

25 December 2017

Kiat Ruxrungtham

8

object named as

Kiat Ruxrungtham

1 reference

25 December 2017

Jintanat Ananworanich

2

object named as

Jintanat Ananworanich

1 reference

25 December 2017

Nicolas Durier

1

1 reference

25 December 2017

Tanakorn Apornpong

3

1 reference

25 December 2017

Sasiwimol Ubolyam

4

1 reference

25 December 2017

Apicha Mahanontharit

6

1 reference

25 December 2017

Laurent Ferradini

7

1 reference

25 December 2017

Anchalee Avihingsanon

9

1 reference

25 December 2017

language of work or name

English

0 references

publication date

19 March 2013

1 reference

25 December 2017

Clinical Infectious Diseases

published in

1 reference

25 December 2017

volume

57

1 reference

25 December 2017

issue

1

1 reference

25 December 2017

page(s)

147-155

1 reference

25 December 2017

Retinal and extraocular cytomegalovirus end-organ disease in HIV-infected patients in Europe: a EuroSIDA study, 1994-2001.

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT173

Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT173

Treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT173

Prognostic factors of survival of HIV-infected patients with cytomegalovirus disease: Aquitaine Cohort, 1986-1997. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT173

Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT173

Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT173

Risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT173

Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy. Spanish CMV-AIDS Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT173

Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT173

Cytomegalovirus (CMV) and human immunodeficiency virus (HIV) burden, CMV end-organ disease, and survival in subjects with advanced HIV infection (AIDS Clinical Trials Group Protocol 360).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT173

Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT173

Cytomegalovirus retinitis: the neglected disease of the AIDS pandemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT173

Stability of hepatitis C virus, HIV, and hepatitis B virus nucleic acids in plasma samples after long-term storage at -20°C and -70°C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT173

Prevalence, risk factors, and impact on outcome of cytomegalovirus replication in serum of Cambodian HIV-infected patients (2004-2007).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT173

Cytomegalovirus viremia as a risk factor for mortality prior to antiretroviral therapy among HIV-infected gold miners in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT173

Clinical relevance of cytomegalovirus viraemia(*,†).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT173

Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT173

Quantitative effects of valacyclovir on the replication of cytomegalovirus (CMV) in persons with advanced human immunodeficiency virus disease: baseline CMV load dictates time to disease and survival. The AIDS Clinical Trials Group 204/Glaxo Wellcom

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT173

Value of necropsy in acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT173

CMV retinitis screening and treatment in a resource-poor setting: three-year experience from a primary care HIV/AIDS programme in Myanmar

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT173

Estimated mortality of adult HIV-infected patients starting treatment with combination antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT173

Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT173

Low rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: results of ACTG protocol A5030.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT173

Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV-positive patients at high risk of CMV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT173

Loss of cytomegalovirus (CMV) viraemia following highly active antiretroviral therapy in the absence of specific anti-CMV therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT173

21 January 2018

Identifiers

DOI

10.1093/CID/CIT173

1 reference

25 December 2017

1 reference

25 December 2017